Clover Health to Participate in Upcoming Investor Conferences
Clover Health (Nasdaq: CLOV) has announced its participation in two major upcoming investor conferences in May 2025. Chief Financial Officer Peter Kuipers will lead the company's presence at these events:
- A presentation at the 2025 Bank of America Healthcare Conference on May 14, 2025, at 6:00 p.m. Eastern Time, which will be available via live webcast and replay on Clover's investor relations website
- Participation in the 22nd Annual Craig-Hallum Institutional Investor Conference on May 28, 2025
Clover Health (Nasdaq: CLOV) ha annunciato la sua partecipazione a due importanti conferenze per investitori previste per maggio 2025. Il Chief Financial Officer Peter Kuipers guiderà la presenza dell'azienda a questi eventi:
- Una presentazione alla Bank of America Healthcare Conference 2025 il 14 maggio 2025 alle 18:00 ora Eastern, disponibile in diretta streaming e in replica sul sito web delle relazioni con gli investitori di Clover
- Partecipazione alla 22ª Conferenza Annuale Craig-Hallum per Investitori Istituzionali il 28 maggio 2025
Clover Health (Nasdaq: CLOV) ha anunciado su participación en dos importantes conferencias para inversores que se celebrarán en mayo de 2025. El Director Financiero Peter Kuipers liderará la presencia de la compañía en estos eventos:
- Una presentación en la Conferencia de Salud Bank of America 2025 el 14 de mayo de 2025 a las 6:00 p.m. hora del Este, que estará disponible vía webcast en vivo y en repetición en el sitio web de relaciones con inversores de Clover
- Participación en la 22ª Conferencia Anual Craig-Hallum para Inversores Institucionales el 28 de mayo de 2025
Clover Health (나스닥: CLOV)는 2025년 5월에 열리는 두 개의 주요 투자자 컨퍼런스에 참가할 것임을 발표했습니다. 최고재무책임자 Peter Kuipers가 회사 대표로 이 행사들에 참석할 예정입니다:
- 2025년 5월 14일 오후 6시(동부 시간)에 열리는 2025 Bank of America Healthcare Conference에서의 발표로, Clover 투자자 관계 웹사이트에서 생중계 및 다시보기로 제공됩니다
- 2025년 5월 28일에 열리는 제22회 Craig-Hallum 기관 투자자 컨퍼런스 참가
Clover Health (Nasdaq : CLOV) a annoncé sa participation à deux importantes conférences pour investisseurs prévues en mai 2025. Le Directeur Financier Peter Kuipers dirigera la présence de l'entreprise lors de ces événements :
- Une présentation à la Conférence Healthcare Bank of America 2025 le 14 mai 2025 à 18h00 heure de l'Est, disponible en webcast en direct et en replay sur le site des relations investisseurs de Clover
- Participation à la 22e Conférence Annuelle Craig-Hallum pour Investisseurs Institutionnels le 28 mai 2025
Clover Health (Nasdaq: CLOV) hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im Mai 2025 angekündigt. Finanzvorstand Peter Kuipers wird die Präsenz des Unternehmens bei diesen Veranstaltungen leiten:
- Eine Präsentation auf der Bank of America Healthcare Conference 2025 am 14. Mai 2025 um 18:00 Uhr Eastern Time, die live per Webcast übertragen und auf der Investor-Relations-Website von Clover als Wiederholung verfügbar sein wird
- Teilnahme an der 22. jährlichen Craig-Hallum Institutional Investor Conference am 28. Mai 2025
- None.
- None.
WILMINGTON, Del., April 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced its participation in the following investor conferences:
- CFO, Peter Kuipers, will present at the 2025 Bank of America Healthcare Conference on Wednesday, May 14, 2025, at 6:00 p.m. Eastern Time. A live webcast and replay of the presentation will be accessible from Clover Health's investor relations website at https://investors.cloverhealth.com/.
- CFO, Peter Kuipers, will participate in the 22nd Annual Craig-Hallum Institutional Investor Conference on Wednesday, May 28, 2025.
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
Investor Relations:
Ryan Schmidt
investors@cloverhealth.com
Press Inquiries:
press@cloverhealth.com
FAQ
When is Clover Health (CLOV) presenting at the Bank of America Healthcare Conference 2025?
How can investors watch Clover Health's (CLOV) presentation at the Bank of America Healthcare Conference?
Which investor conferences will Clover Health (CLOV) attend in May 2025?
Who will represent Clover Health (CLOV) at the upcoming investor conferences?
